Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal
Date of publication: 23-10-2017
Suspend further administration of octagam 10% from production lots K724B8541 and K725A8541. Źródło: https://www.fda.gov
